<p>Cell Death Processes: Neurons and Glia.- Neuronal Necrosis.- Neuronal Apoptosis.- Autophagy Pathways.- Necrostatin Neuroprotection.- Neuronal Necroptosis, Relation to Neurological Disorders.- Multiple Cell Death Processes in Neurological Disorders.- Micorglia: Neuroprotective and Neurodestructive Propertie.s, - Selective Neurotoxins.- Survey of Selective Neurotoxinx .- RCSN Cell System for Identifying Dopaminergic Neurotoxicity.- Neurotoxicity: A complex multistage process.- Dopaminergic and Noradrenergic Neurotoxins.- Dopamine and L-dopa as Selective Endogenous Neurotoxins., Dopamine D2 Receptor Supersensitivity as a non-Degenerative Neurotoxin.- Trace Amine-Associated Receptor 1 (TAAR1) and Doapmine Receptor Sensitivity.- Dopamine Receptor Supersensitivity to Model Schizophrenia.- Pathophysiology of Obsessive-Compulsive Disorder: Insights from Normal Function and Neurotoxic Effects of Drugs, Infection, and Brain Injury.- Dopamine D3 receptors and schizophrenia / drug addiction.- Tardive Dyskinesia: Outcome of Antipsychotic Treatment and Brain Damage?.- 6-Hydroxydopamine Neurotoxicity in Adult Animal.- 6-Hydroxydopamine Neurotoxicity in Perinatal Animals.- 6-Hydroxydopa in Perinatal and Adult Animals.- MPTP Neurotoxicity Mechanisms.- Dopaminergic and Noradrenergic Neurotoxins and Neurodegenerative Disorders.- anti-NGF.- Advances in Stem Cell Research for Parkinson's Disease.- Autophagy Pathways and Parkinson's Disease.- Regulation of DA Homeostasis and Role of VMAT2 in Parkinson's Disease.- Alpha-Synuclein in Parkinson's Disease.- Dopaminergic Neurons in Parkinson's Disease.- Dopamine Oxidation and Parkinson's Disease.- Neuromelanin and Parkinson's Disease., -Iron-Induced Dopaminergic Cell Death in vivo as a Model of Parkinson's Disease.- Iron Neurotoxicity in Parkinson's Disease.- 6-Hydroxydopamine as Preclinical Model of Parkinson's Disease. - MPTP modeling of Parkinson's Disease.- MPTP: Advances from and Evergreen Neurotoxin. - MPTP and Motor Neurons.-MPTP Neurotoxicity: Actions, Mechanisms, and Animal Modeling of Parkinson's Disease.- Paraquat and Parkinson's Disease.- Rotenone Preclinical Modeling of Parkinson's Disease.- N-Methyl-(R)-Salsolinol and Parkinson's Disease.- Fusion Models and "Fusioning" in Parkinsonism: 1-Benzyl-1,2,3,4-tetrahydroisoquinoline.- Amphetamines as Neurotoxins.- METH Neurotoxicity.- Neurotoxicity of MDMA.- Cocaine influence of A2/D2 receptor heteromers.- Cocaine as a Neurotoxin.- NBOMe Neurotoxicity.- Cathinone Neurotoxicity - several chapters.- Neurotoxic Vulnerability Underlying Schizophrenia Spectrum Disorders.- Molecular Mechanism and Effects of Clostridial Neurotoxins.- Botulinum Neurotoxicity.- ~3 addl subchapters on Botulinum Neurotoxicity.- Neurotoxic Effects, Mechanisms, and Outcome of 192-IgG Saporin.- TRPV1 Activators ("Vanilloids") as Neurotoxins.- Protective Agents in Parkinson's Disease:Caffeine and Adenosine A2A Receptor Antagonists.- Physical Exercise as Intervention in Parkinsonism.- Manganese Neurotoxicity and Parkinson's Disease.- Neuroinflammation and Parkinson's Disease.- Neurotoxicity in Psychostimulant and Opiate Addiction.- Homocysteine and Cerebellar Damage.- Propionic Acid, Modeling of Autism Spectrum Disorders.- 1-Me-TIQ, and endogenous Neuroprotectant.- 5-MeO-DIPT.- 3-MD-Glutaric acid.- 3-NP and Huntington's Disease.- 25C-NBOMe.- M-30.- Trace amine-associated receptor 1 and neuropsychiatric disorders.- PACAP as a Neuroprotectant.- Doxycycline as a Neuroprotectant .- PCP Modeling Amnesia.- Drug Abuse Neurotoxicity: Alcohol and Nicotine as Developmental Stressors.- Neurotrophic Factors and Ethanol Neurotoxicity.- Salsolinol and Addiction.- Snake Venom Toxins.- Salicylate Ototoxicity.- Serotoninergic Neurotoxins.- Nature of DSP-4-Induced Neurotoxicity.- 5,6- and 5,7-Dihydroxytryptamines as Serotoninergic Neurotoxins.- 2'NH(2)-MPTP: A Serotonin and Norepinephrine Neurotoxin.- Excitotoxins and Excitotoxicity.- Glutamate as a Neurotoxin.- Aspartate as a Neurotoxin.- Concept of Excitotoxicity via Glutamate Receptors .- Glutamate Neurotoxicity, Transport and Alternative Splicing of Transporters.- Excitotoxicity: A Complex Multistage Process Involving Different Mechanisms.- Glutamate Excitotoxicity Relation to Energy Failure.- Ionotropic Receptors in the Central Nervous System and Neurodegenerative Disorders.- Excitotoxicity and Axon Degeneration.- Glutamate Scavengers.- Quinolinate and Related Excitotoxins: Mechanisms of Neurotoxicity and Disease Relevanc.- Domoic Acid as a Neurotoxin.- BOAA and Neurotoxicit.- Endogenous Kynurenic Acid and Neurotoxicity.- Neuroprotection by Kynurenine Metabolites.- BMAA (beta-N-Methylamin.- Ionotropic Glutamate Receptors in Neurodegenerative and Other Disorders.- Okadaic acid modeling of Alzheimer's Disease.- Excitotoxicity in Parkinson's Disease.- Excitotoxicity and the Pathogenesis of Gliomas Excitotoxicity and Epielpsy; Epilepsy re Neurotoxicity Mechs.- Excitotoxicity in Multiple Sclerosis.- Excitotoxicity: Insights into Pathogenesis of AD.- Excitotoxicity and ALS: Insights into Pathogenesis.- Excitotoxicity and Amyotrophic Lateral Sclerosis.- Fungal Neurotoxins and ALS.- Excitotoxicity and Huntington Disease.- Excitotoxicity and Stroke.- Excitotoxicity in HIV Associated Neurocognitive Disordders.- Excitotoxicity and AIDS.- Excitotoxicity and Neuroprotection in Spinal Cord Injury.- Excitotoxicity in the Pathogenesis of Autism.- Cancer-Mediated Excitotoxicity., Excitotoxicity and Depression.- Lead and Excitotoxicity.- Glutamate and Neurodegeneration in the Retina.- Excitotoxicity and Epielpsy.- Seizures, Neurotrophin, Neuronal Death.- Neurodegenerative Aspets of Multiple System Atrophy.- Excitotoxicity in Ischemia and Reperfusion Injury.- Molecular, Cellular, and Behavioural Effects Produced by Perinatal Asphyxia: Neuroprotectants Targeting NMDA Receptor Signaling.- Neuroprotective Strategies in Amyotrophic Lateral Sclerosis Modulation ofNeurotransmitory and Neurotrophic Input to Motor Neurons.- Neuroprotection in Demyelinating Diseases: The Therapeutic Potential of the Neurotrophins.- p75NTR: A Molecule with Multiple Functions in Amyloid-beta.- Metabolism and Neurotoxicity.- Neurotrophins and ALS.- Neurotrophic Factors & NeuroAIDS.- Neuroprotection by Poly (ADP-Ribose) Polymerase 1 (PARP-1) Inhibition.- Alzheimer's Disease and Neurotoxic Aspects.- Stem Cell Therapies for Age Associated Neurodegeneration.- Pathogenesis of Alzheimer's Disease.- Experimental Approach to Alzheimer Disease.- Potential Therapeutic Effects of Statins in Alzheimer's Disease.- Excitotoxicity and Alzheimer's Disease: Treatment Challenges.- Amyloid-beta, BDNF, and Mechanism of Neurodegeneration in Alzheimer's Diseases.- Drug Treatments: hopes, challenges.- Cannabinoids and Alzheimer's.- Heavy Metal Neurotoxicity.- Trimethyltin Neurotoxicity.- Mn Neurotoxicity.- MeHG.- Cd Neurotoxicity.- Fe Neurotoxicity.- Organoselenium.- Al Neurotoxicity.- SeNeurotoxicity.- Pb Neurotoxicity.- Cuprizone modelin of Multiple sclerosis.</p><p></p>